At OPEN Health, the excitement is building for pH Associates and OPEN Access Consulting as we prepare for our imminent return to ISPOR’s Annual European Congress, being held in Glasgow this year (www.ispor.org/Event/index/2017Glasgow).
We are proud to be presenting 15 posters this year, including four of which have been nominated as ISPOR Research Presentation Award Finalists:
- Work productivity in HER2 positive breast cancer: a comparison of patients across stages of early and metastatic disease (PCN234)
- A multi-centre retrospective study to describe the impact on healthcare resource use and real world effectiveness of golimumab in ankylosing spondylitis (AS) in UK clinical practice (PMS97)
- The use of real world evidence data for NICE decision-making: a review of submissions to three treatment effectiveness evaluation programmes in 2015 and 2016 (PHP239)
- Does the early bird catch the worm? Early cancer detection and survival in the UK (PHS77)
Come and visit us at ISPOR Stand 105, where we’ll be delighted to discuss your Real World Evidence and Market Access needs. You can also find out about some of the exciting things we have been up to recently, including the launch of REAL Europe (www.realrwe.com) – a brand new alliance between pH and specialist Real World Evidence partners in Europe, allowing us to strengthen our capabilities in Europe and beyond.
Have your say about Real World Evidence Gaps at Stand 105, where we’ll be running an interactive survey. Evidence is only as strong as its weakest gap; we want to learn more about what’s driving or dragging your real world evidence initiatives.
A few minutes of your time can make a difference as pH Associates and OPEN Access Consulting will make a donation to our specially chosen charity: Médecins Sans Frontières (Doctors Without Borders, www.msf.org.uk), the international humanitarian organisation, known particularly for providing medical aid in war-torn regions and developing countries.
So, don’t forget, we’ll be at Stand 105 – come and say ‘Hello’!